相关实验视频

Updated: Sep 10, 2025

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

新生儿囊性纤维化查

Ambika Shenoy¹, Nilesh Seshadri², Haley Haskett²

¹Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA.

Clinics in perinatology

|August 24, 2025

概括

新生儿囊性纤维化查 (CF NBS) 可以提前诊断并改善结果. 尽管存在实施挑战,但对所有婴儿进行及时,公平的CF诊断仍然是首要目标.

科学领域:

医学遗传学
儿童医学
公共卫生

背景情况:

新生儿查 (NBS) 囊性纤维化 (CF) 对于早期诊断和改善临床结果至关重要.
结核病的首要目标是确保所有受影响的婴儿得到及时和公平的诊断.
现有的CFNBS协议和算法对于识别CF的婴儿至关重要.

研究的目的:

概述囊性纤维化新生儿查中的过程和算法.
审查与CF NBS相关的测试和临床结果.
确定CF NBS最佳实施的未来需求和挑战.

主要方法:

审查目前的囊性纤维化新生儿查方案和算法.
对婴儿查CF的测试方法和临床结果的分析.
确定CF NBS实施的挑战和未来方向.

主要成果:

导致早期诊断和更好的临床结果.
国家级CF NBS协议存在显著差异,影响了实施.
挑战包括管理不确定的测试结果和确保及时评估和治疗.

结论:

优化CFNBS需要解决状态协议的变化和改善诊断途径.
加强对初级提供者和家庭的教育对于有效的CF NBS至关重要.
资金中心与国家计划之间的强有力的伙伴关系对于成功实施资金系统至关重要.

关键词:

囊性纤维化胎儿治疗遗传学新生儿查

更多相关视频

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...